Found: 1
Select item for more details and to access through your institution.
IMM-BCP-01, a patient-derived anti–SARS-CoV-2 antibody cocktail, is active across variants of concern including Omicron BA.1 and BA.2.
- Published in:
- Science Immunology, 2022, v. 7, n. 75, p. 1, doi. 10.1126/sciimmunol.abl9943
- By:
- Publication type:
- Article